CIMDUO Drug Patent Profile
✉ Email this page to a colleague
When do Cimduo patents expire, and what generic alternatives are available?
Cimduo is a drug marketed by Mylan Labs Ltd and is included in one NDA.
The generic ingredient in CIMDUO is lamivudine; tenofovir disoproxil fumarate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lamivudine; tenofovir disoproxil fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIMDUO?
- What are the global sales for CIMDUO?
- What is Average Wholesale Price for CIMDUO?
Summary for CIMDUO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CIMDUO |
| What excipients (inactive ingredients) are in CIMDUO? | CIMDUO excipients list |
| DailyMed Link: | CIMDUO at DailyMed |
US Patents and Regulatory Information for CIMDUO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | CIMDUO | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022141-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
